EEF1DP3: A Potential Drug Target and Biomarker (G196549)

Target Name: EEF1DP3

NCBI ID: G196549

EEF1DP3

Other Name(s): Eukaryotic translation elongation factor 1 delta pseudogene 3 | eukaryotic translation elongation factor 1 delta pseudogene 3

EEF1DP3: A Potential Drug Target and Biomarker

EEF1DP3, also known as EEF1D and EEF1-DP3, is a protein that is expressed in various tissues of the body, including the brain, heart, and pancreas. Its function is not well understood, but it is involved in several cellular processes that are crucial for normal cellular function. There is limited research on this protein, which makes it an attractive target for drug development. In this article, we will discuss the potential drug target and biomarker of EEF1DP3.

Drug Target

EEF1DP3 is a protein that can interact with several drug targets, including G protein-coupled receptors (GPCRs), which are a family of transmembrane proteins that play a crucial role in cellular signaling. GPCRs are involved in many physiological processes, including sensory perception, neurotransmission, and hormone signaling. Therefore, blocking GPCRs can be an effective way to treat various diseases.

EEF1DP3 has been shown to interact with several GPCRs, including GPCR7, GPCR12, and GPCR18. GPCR7 and GPCR12 are involved in insulin signaling, while GPCR18 is involved in glucagon signaling. Blocking these GPCRs can lead to decreased insulin or glucagon levels, which can improve the efficacy of anti-diabetic drugs. Additionally, blocking GPCR7 has been shown to be effective in treating anxiety disorders.

Biomarker

EEF1DP3 has also been shown to be involved in the regulation of inflammation. Chronic inflammation is associated with many diseases, including cardiovascular disease, diabetes, and neurodegenerative disorders. Therefore, targeting EEF1DP3 may be a promising way to treat these diseases.

EEF1DP3 has been shown to regulate the activity of immune cells, including T cells and macrophages. These immune cells play a crucial role in maintaining cellular and tissue health, and dysregulation of immune cells has been implicated in many diseases, including cancer and autoimmune disorders. Therefore, targeting EEF1DP3 may be a promising way to treat these diseases.

Conclusion

EEF1DP3 is a protein that is involved in several cellular processes that are crucial for normal cellular function. While its function is not well understood, it has been shown to interact with several drug targets, including GPCRs and immune cells. Therefore, targeting EEF1DP3 may be a promising way to develop new treatments for various diseases. Further research is needed to fully understand its function and develop effective therapies.

Protein Name: Eukaryotic Translation Elongation Factor 1 Delta Pseudogene 3

The "EEF1DP3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EEF1DP3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets